Экспрессия генов раннего ответа и генов каспаз как возможный диагностический маркер при развитии рака шейки матки
Диссертация
Данные, полученные при выполнении диссертационного исследования, указывают на то, что протоонкогены с-тус, с-/о$, с-]ип и гены каспаз (-3,-6,-8,-9) занимают важное место в молекулярном «портрете» ЦИН 3 и РШМ и характеризуют процессы формирования основных фенотипических характеристик опухолипролиферативный потенциал и устойчивость к апоптоз-индуцирующим факторам. Анализ экспрессии генов раннего… Читать ещё >
Список литературы
- Анисимов, А.Г., Болотников, И.А. Обработка синхронизированных клеток К562 тетрафторалюминатом не модулирует флуоресценцию бромистого этидия и 4', 6-диамидино-2-фенилиндола при связывании с нуклеоидной ДНК // Цитология. — 1999. Т.41. — № 8. — С.680−684.
- Иванов, С.Д. Пострадиационные реакции ДНК нуклеоидов лейкоцитов крови. Детектирование, закономерности, диагностическое и прогностическое значение: автореф. дис.. д-ра биол. наук: 03.00.01 / Иванов Сергей Дмитриевич. — СПб., 1992. -40 с.
- Имянитов, Е.Н. Молекулярные механизмы опухолевого роста // Вопросы онкологии. -2010. -Т.56. № 2. — С. 117−128.
- Мерабишвили, В.М., Лалианци, Э.И., Субботина О. Ю. Рак шейки матки: заболеваемость, смертность (популяционное исследование) // Вопросы онкологии. — 2012. Т.58. — № 1. — С.41−44.
- ПЦР «в реальном времени» / Ребриков Д. В., Саматов Г. А., Трофимов Д. Ю. и др.- под ред. д.б.н. Д. В. Ребрикова. — М.: БИНОМ. Лаборатория знаний, 2009. — 215 с.
- TNM: Классификация злокачественных опухолей / Л. Х. Собин, М. К. Господарович, К. Виттекинд- пер. с анг. под ред. Н. Н. Блинова. — 6-е изд. — СПб.: Эскулап, 2003. -244 с.
- Хаитов, P.M. Руководство по клинической иммунологии. Диагностика заболеваний иммунной системы / Р. М. Хаитов, Б. В. Пинегин, А. А. Ярилин. — М.: ГЭОТАР-Медиа, 2009. 354 с.
- Abd el All, Н., Rey, A., Duvillard, P. Expression of heat shock protein 70 and c-myc in cervical carcinoma // Anticancer Research. — 1998. — Vol. 18. — № 3A. — P. 1533−1536.
- Adamopoulou, M., Kalkani, E., Charvalos, E., et al. Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia // Anticancer Research. — 2009. Vol.2. — № 8. — P.3401−3409.
- Aguilar-Lemarroy, A., Romero-Ramos, J.E., Olimon-Andalon, V., et al. Apoptosis induction in Jurkat cells and sCD95 levels in women’s sera are related with the risk of developing cervical cancer // BMC Cancer. — 2008. — № 8. — P.99.
- Ali, K.S., Ali, H.Y., Jubrael, J.M. Concentration levels of IL-10 and TNFa cytokines in patients with human papilloma virus (HPV) DNA+ and DNA" cervical lesions // Journal of Immunotoxicology. 2012. — Vol.9. — № 2. — P. 168−172.
- Andersson, S., Safari, H., Mints, M., et al. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN) // British Journal of Cancer. 2005. — Vol.92. — P.2195 — 2200.
- Anedchenko, E., Oparina, N., Dmitriev, A., et al. Activation of the hTERT expression in squamous cell cervical carcinoma is not associated with gene amplification // Oncology Reports. 2008. — Vol.20. — P.469−474.
- Antinore, M.J., Birrer, M.J., Patel, D., et al. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the API family of transcription factors // The EMBO Journal. 1996. — Vol.15. — № 8. — P. 1950−1960.
- Arechaga-Ocampo, E., Pereira-Suarez, A.L., del Moral-Hernandez, O., et al. HPV+ cervical carcinomas and cell lines display altered expression of caspases // Gynecologic Oncology. 2008. — Vol. 108. — P. 10−18.
- Arvanitis, D.A., Spandidos, D.A. Deregulation of the Gl/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study // Oncology Reports. 2008. — Vol.20. — № 4. — P.751−760.
- Bae, S.M., Lee, C.H., Cho, Y.L., et al. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients // Gynecologic Oncology. — 2005. — Vol.99. — № 1. — P.26−35.
- Bais, A.G., Beckmann, I., Lindemans, J., et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions // Journal of Clinical Pathology. 2005. — Vol.58. — № 10. — P. 1096−1100.
- Bhattacharjee, B., Sengupta, S. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2 // Virology. — 2006. Vol.354. — P.280−285.
- Bolpetti, A., Silva, J.S., Villa, L.L., et al. Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth // BMC Immunology. -2010. -№ 11.-P.27.
- Bourhis, J., Le, M.G., Barrois, M., et al. Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix // Journal of Clinical Oncology. — 1990. Vol.8. — № 11. — P. 1789−1796.
- Bozec, A., Ruffion, A., Decaussin, M., et al. Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia // The Journal of Clinical Endocrinology and Metabolism. 2005. — Vol.90. -№ 1. — P. 17−25.
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding // Analytical Biochemistry. —1976. -Vol.72. -P.248−254.
- Brenna, S.M., Zeferino, L.C., Pinto, G.A., et al. c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma // Brazilian Journal of Medical and Biological Research. 2002. — Vol.35- № 4. — P.425−430.
- Brewer, C.A., Liao, S.Y., Wilczynski, S.P., et al. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN // Gynecologic Oncology. — 1996. Vol.63. — № 3. — P.337−344.
- Bustin, S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays // Journal of Molecular Endocrinology. — 2000. — Vol.25. P. 169−193.
- Bustin, S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems I I Journal of Molecular Endocrinology. — 2002. — Vol.29. — P.23−39.
- Cheriyan, V.T., Krishna, S.M., Kumar, A., et al. Signaling defects and functional impairment in T-cells from cervical cancer patients // Cancer Biotherapy and Radiopharmaceuticals. 2009. — Vol.24. -№ 6. — P.667−674.
- Chernysh, S., Kim, S.I., Bekker, G., et al. Antiviral and antitumor peptides from insects // Proceedings of the National Academy of Sciences. — 2002. — Vol.99. — № 20. P. 1 262 812 632.
- Cheung, T.H., Chung, T.K., Lo, K.W., et al. Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix // Gynecologic Oncology. 2002. — Vol.86. -№ 1. — P. 14−18.
- Chiang, S. Y., Welch, J., Rauscher, F.J. 3rd, et al. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA // Biochemistry. — 1994. Vol.33. -№ 23. -P.7033−7040.
- Contreras, D.N., Krammer, P.H., Potkul, R.K., et al. Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes // Journal of Immunotherapy. — 2000. — Vol.23. — № 1. — P.67−74.
- Cook, P.R., Brazell, I. A. Spectofluorometric measurement of the binding of ethidium to superhelical DNA from cell nuclei // European Journal of Biochemistry. — 1978. — Vol.84. -P.465−477.
- Couturier, J., Sastre-Garau, X., Schneider-Maunoury, S., et al. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression // Journal of Virology. — 1991. — Vol.65. — № 8. — P.4534−4538.
- Cromme, F.V., Snijders, P.J., van den Brule, A.J., et al. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression // Oncogene. — 1993. — Vol.8. — № 11. — P.2969−2975.
- Dang, C.V. MYC on the path to cancer // Cell. 2012. — Vol. 149. — № 1. — P.22−35.
- Das, S., Karim, S., Datta, R.C., et al. Peripheral blood lymphocyte subpopulations in patients with cervical cancer // International Journal of Gynecology and Obstetrics. — 2007. Vol.98. — № 2. — P. 143−146.
- Demeret, C., Garcia-Carranca, A., Thierry, F. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein // Oncogene. — 2003. Vol.22. — № 2. — P. 168−175.
- Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer // Clinical Science. 2006. — Vol.110. — P.525−541.
- Du, J., Chen, G.G., Vlantis, A.C., et al. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression // Cancer Letters. 2004. — Vol.205. -№ 1. -P.81−88.
- Duenas-Gonzalez, A., Lizano, M., Candelaria, M., et al. Epigenetics of cervical cancer. An overview and therapeutic perspectives // Molecular Cancer. — 2005. — № 4. — P.38.
- Dworacki, G., Meidenbauer, N., Kuss, I., et al. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma // Clinical Cancer Research. 2001. — Vol.7. -№ 3(Suppl). — P.947s-957s.
- Eferl, R., Wagner, E.F. AP-1: A double-edged sword in tumorigenesis // Nature Reviews. Cancer. -2003. Vol.3. -№ 11. -P.859−868.
- Eilers, M., Eisenman, R.N. Myc’s broad reach // Genes and Development. — 2008. — Vol.22. P.2755−2766.
- Ekonomopoulou, M.T., Babas, E., Mioglou-Kalouptsi, E., et al. Changes in activities of caspase-8 and caspase-9 in human cervical malignancy // Internatinal Journal of Gynecological Cancer. 2011. — Vol.21. — № 3. — P.435−438.
- Fahey, L.M., Raff, A.B., Da Silva, D.M., et al. A major role for the minor capsid protein of human papillomavirus type 16 in immune escape // Journal of Immunology. — 2009. — Vol.183. -№ 10. -P.6151−6156.
- Ferber, M.J., Thorland, E.C., Brink, A.A., et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma // Oncogene. — 2003. — Vol.22. -P.7233−7242.
- Frazer, I.H. Interaction of human papillomaviruses with the host immune system: A well evolved relationship // Virology. 2009. — Vol.384. — P.410−414.
- Gadducci, A., Guerrieri, M.E., Greco, C. Tissue biomarkers as prognostic variables of cervical cancer // Critical Reviews in Oncology/Hematology. — 2012. — pii: S1040−8428(12)00186−2. doi: 10.1016/j.critrevonc.2012.09.003.
- Gandarillas, A., Watt, F.M. Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes // Oncogene. — 1995. Vol. 11. — № 7. — P. 1403−1407.
- Gibb, E.A., Becker-Santos, D.D., Enfield, K.S., et al. Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasia // International Journal of Gynecological Cancer. 2012. — Vol.22. — № 9. — P. 1557−1563.
- Gius, D., Funk, M.C., Chuang, E.Y., et al. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates // Cancer Research. -2007. Vol.67. -№ 15,-P.7113−7123.
- Gupta, M.M., Jain, R., Parashari, A., et al. Circulating immune profile in patients with precancer and cancer of the cervix: a cross sectional study among Indian women // Bulletin du Cancer. 1993. — Vol.80. -№ 10. -P.852−856.
- Hammes, L.S., Tekmal, R.R., Naud, P., et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression -clinicopathological correlation // Gynecologic Oncology. 2007. — Vol. 105. — № 1. — P. 157−165.
- Hansen, C.N., Ketabi, Z., Rosenstierne, M.W. Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development // Acta Pathologica, Microbiologica, et Immunologica Scandinavica. — 2009. — Vol. 117. — № 1. — P.53−59.
- Helm, C.W., Shrestha, K., Thomas, S., et al. A unique c-myc-targeted triplex-forming oligonucleotide inhibits the growth of ovarian and cervical carcinomas in vitro // Gynecologic Oncology. 1993. — Vol.49. -№ 3. — P.339−343.
- Hess, J., Angel, P., Schorpp-Kistner, M. AP-1 subunits: quarrel and harmony among siblings // The Journal of Cell Science. 2004. — Vol.117. — P.5965−5973.
- Higareda-Almaraz, J.C., Enriquez-Gasca, M.R., Hernandez-Ortiz, M., et al. Proteomic patterns of cervical cancer cell lines, a network perspective // BMC Systems Biology. — 2011. — № 5. — P.96.
- Но, P.K., Hawkins, C.J. Mammalian initiator apoptotic caspases // FEBS Journal. — 2005. Vol.272. — № 21. — P.5436−5453.
- Hoffmann, Т.К., Dworacki, G., Tsukihiro, Т., et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance // Clinical Cancer Research. 2002. — Vol.8. — № 8. — P.2553−2562.
- Hoser, G., Wasilewska, D., Domagala-Kulawik, J. Expression of Fas receptor on peripheral blood lymphocytes from patients with non-small cell lung cancer // Folia Histochemica et Cytobiologica. 2004. — Vol.42. — № 4. — P.249−252.
- Hughes, R.G., Neill, W.A., Norval, M. Papillomavirus and c-myc antigen expression in normal and neoplastic cervical epithelium // Journal of Clinical Pathology. — 1989. — Vol.42.-№ 1.-P.46−51.
- Hwang, S.J., Shroyer, K.R. Biomarkers of cervical dysplasia and carcinoma // Journal of Oncology. -2012. doi: 10.1155/2012/507 286.
- Ibeanu, O.A. Molecular pathogenesis of cervical cancer // Cancer Biology and Therapy. — 2011. Vol.11. -№ 3. -P.295−306.
- Ibrahim, R., Frederickson, H., Parr, A., et al. Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism // Cancer. 2006. — Vol. 106. — № 5. — P. 1065−1077.
- Isacson, C., Kessis, T.D., Hedrick, L., et al. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type // Cancer Research. 1996. — Vol.56. — № 4. — P.669−674.
- Iwasaka, Т., Yokoyama, M., Oh-uchida, M., et al. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas // Gynecologic Oncology. 1992. — Vol.46. — № 3. — P.298−303.
- Jager, R., Zwacka, R.M. The enigmatic roles of caspases in tumor development 11 Cancers. -2010. Vol.2. — № 4. -R1952−1979.
- Kabsch, K., Alonso, A. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms // Journal of Virology. — 2002. Vol.76. -№ 23. — P. 12 162−12 172.
- Kanodia, S., Da Silva, D.M., Kast, W.M. Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions // International Journal of Cancer. — 2008. — Vol.122.-P.247−259.
- Kanodia, S., Fahey, L.M., Kast, W.M. Mechanisms used by human papillomaviruses to escape the host immune response // Current Cancer Drug Targets. — 2007. — № 7. — P. 79−89.
- Karim, R., Jordanova, E.S., Piersma S.J., et al. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma // Clinical Cancer Research. 2009. — Vol. 15. — № 20. — P.6341−6347.
- Kim, H.H., Kuwano, Y., Srikantan, S., et al. HuR recruits let-7/RISC to repress c-Myc expression // Genes and Development. — 2009. Vol.23. — № 15. — P. 1743−1748.
- Kim, J.W., Kim, S.J., Han, S.M., et al. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human cervical cancers // Gynecologic Oncology. — 1998. Vol.71. — № 2. — P.266−269.
- Kinoshita, T., Shirasawa, H., Shino, Y., et al. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein // Virology. — 1997. — Vol.232. -№ 1. -P.53−61.
- Kobayashi, A., Weinberg, V., Darragh, T., et al. Evolving immunosuppressive microenvironment during human cervical carcinogenesis // Mucosal Immunology. — 2008. -Vol.1. — № 5. P.412−420.
- Kohler, M., Janz, I., Wintzer, H.O., et al. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance // Anticancer Research. — 1989. — Vol.9. — № 6. — P. 1537−1547.
- Korzeniewski, N., Spardy, N., Duensing, A., et al. Genomic instability and cancer: lessons learned from human papillomaviruses // Cancer Letters. — 2011. — Vol.305. — № 2. — P.113−122.
- Kossenkov, A.V., Dawany, N., Evans, T.L., et al. Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer // PLoS One. — 2012. — Vol.7.3. — P. e34392.
- Kossenkov, A.V., Vachani, A., Chang, C., et al. Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system // Clinical Cancer Research. 2011. — Vol.17. — P.5867−5877.
- Kyo, S., Klumpp, D.J., Inoue M., et al. Expression of API during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells // Journal of General Virology. 1997. — Vol.78. — P.401−411.
- Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 // Nature. 1970. — Vol.227. — P.680−685.
- Lagunas-Martinez, A., Madrid-Marina, V., Ganglio, P. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer // Biochimica et Biophysica Acta. — 2010.-Vol.1805.-P.6−16.
- Lakatosh, V.P., Lazarenko, L.M., Spivak, M.I., et al. The determination of the cellular immunity indices in papillomavirus infection of the female genitalia // Lik Sprava. — 1999. — № 4. — P.98−102.
- Laurson, J., Khan, S., Chung, R., et al. Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein // Carcinogenesis. — 2010. — Vol.31. — № 5. — P.918−926.
- Lee, J.S., Kim, H.S., Jung, J.J., et al. Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia // Analytical and Quantitative Cytology and Histology. — 2002. Vol.24. — № 2. — P. 103−113.
- Livak, K.J., Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method // Methods. 2001. — Vol. 25. -№ 4. — P.402−408.
- Loddenkemper, C., Hoffmann, C., Stanke, J., et al. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer // Cancer Science. 2009. — Vol. 100. — № 6. — P. 1112−1117.
- Lomnytska, M.I., Becker, S., Hellman, K., et al. Diagnostic protein marker patterns in squamous cervical cancer // PROTEOMICS Clinical Applications. — 2010. — Vol.4. — № 1.-P. 17−31.
- Longworth, M.S., Laimins, L.A. Pathogenesis of human papillomaviruses in differentiating epithelia // Microbiology and Molecular Biology Reviews. — 2004. — Vol. 68. -№ 2. P. 362−372.
- Ma, Y., Shurin, G.V., Peiyuan, Z., et al. Dendritic cells in the cancer microenvironment //Journal of Cancer. -2013. Vol.4. -№ 1. — P.36−44.
- Mahata, S., Bharti, A.C., Shukla, S., et al. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells // Molecular Cancer. — 2011. — Vol.15. —№ 10. — P.39.
- Maritz, M.F., van der Watt, P.J., Holderness, N., et al. Inhibition of AP-1 suppresses cervical cancer cell proliferation and is associated with p21 expression // Biological Chemistry. -2011. Vol.392. — № 5. -P.439−448.
- McMurray, H.R., McCance, D.J. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression // Journal of Virology. 2003. — Vol.77. -№ 18. — P.9852−9861.
- Milde-Langosch, K. The Fos family of transcription factors and their role in tumourigenesis // European Journal of Cancer. — 2005. — Vol.41. — P.2449−2461.
- Moody, C.A., Laimins, L.A. Human papillomavirus oncoproteins: pathways to transformation // Nature Reviews Cancer. — 2010. — Vol. 10. — № 8. — P.550−560.
- Moro-Rodriguez, E., Alvarez-Fernandez, E. Losses of expression of the antigens A, Lea and Lex and over-expression of Ley in carcinomas and HG-SIL of the uterine cervix // Diagnostic Pathology. 2008. — № 3. — P.38.
- Morosov, A., Phelps, W.C., Raychaudhuri, P. Activation of the c-fos gene by the HPV16 upon the CAMP-response element at -60 // The Journal of Biological Chemistry. — 1994. Vol.269. — № 28. — P. 18 434−18 440.
- Mota, F., Rayment, N., Chong, S., et al. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium // Clinical and Experimental Immunology. — 1999. — Vol. 116. — № 1. P.33−40.
- Nair, S.A., Nair, M.B., Jayaprakash, P.G., et al. Ras and c-myc oncoproteins during tumor progression in the uterine cervix // Tumori. — 1998. — Vol.84. — № 5. — P.583−588.
- Narayan, G., Murty, V.V. Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis // Future Oncology. — 2010. — Vol.6. — № 10. — P. 1643−1652.
- Nead, M.A., Baglia, L.A., Antinore, M.J., et al. Rb binds c-Jun and activates transcription // The EMBO Journal. 1998. — Vol. 17. — № 8. — P.2342−2352.
- Ngan, H.Y., Liu, S.S., Yu, H., et al. Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia // European Journal of Cancer. 1999. — Vol.35. — № 10. — P. 1546−1550.
- Nirnberg, W., Artuc, M., Vorbrueggen, G., et al. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter // British Journal of Cancer. — 1995. Vol.71.-P. 1018−1024.
- Oh, E.K., Kim, Y.W., Kim, I.W., et al. Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma // International Journal of Oncology. -2012. Vol.41. -№ 6. — P.2038−2046.
- O’Leary, J.J., Landers, R.J., Crowley, M., et al. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma // Journal of Clinical Pathology. 1997. — Vol.50. -№ 11. -P.896−903.
- Olsson, M., Zhivotovsky, B. Caspases and cancer // Cell Death and Differentiation. — 2011. -№ 18.-P. 1441−1449.
- Peter, M., Rosty, C., Couturier, J., et al. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors // Oncogene. — 2006. — Vol.25. — P.5985−5993.
- Petera, J., Sirak, I., Beranek, M., et al. Molecular predictive factors of outcome of radiotherapy in cervical cancer // Neoplasma. — 2011. — Vol.58. — № 6. — P.469−475.
- Petrov, S.V., Mazurenko, N.N., Sukhova, N.M., et al. Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix // Archives of Pathology. 1994. — Vol.56. — № 4. — P.22−31.
- Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR // Nucleic Acids Research. 2001. — Vol.29. — № 9. — P. e45.
- Philchenkov, A., Zavelevich, M., Kroczak, T.J., et al. Caspases and cancer: mechanisms of inactivation and new treatment modalities // Experimental Oncology. — 2004. — Vol.26. — № 2. — P. 82—97.
- Pinion, S.B., Kennedy, J.H., Miller, R.W., et al. Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix // Lancet. — 1991. — Vol.337. — № 8745. — P.819−820.
- Pinto, A.P., Degen, M., Villa, L.L., et al. Immunomarkers in gynecologic cytology: the search for the ideal 'biomolecular Papanicolaou test' // Acta Cytologica. — 2012. — Vol.56. -№ 2. P. 109−121.
- Ponzielli, R., Katz, S., Barsyte-Lovejoy, D., et al. Cancer therapeutics: Targeting the dark side of Myc // European Journal of Cancer. 2005. — Vol.41. — P.2485−2501.
- Rajkumar, T., Sabitha, K., Vijayalakshmi, N., et al. Identification and validation of genes involved in cervical tumourigenesis // BMC Cancer. — 2011. — № 11. — P.80.
- Riou, G., Barrois, M., Le, M.G., et al. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix // Lancet. — 1987. — Vol.1. — № 8536. — P.761−763.
- Rodriguez, A.C., Garcia-Pineres, A.J., Hildesheim, A., et al. Alterations of T-cell surface markers in older women with persistent human papillomavirus infection // International Journal of Cancer. 2011. — Vol. 128. — № 3. — P.597−607.
- Rosl, F., Das, B.C., Lengert, M., et al. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription // Journal of Virology. 1997. — Vol.71. -№ 1. — P.362−370.
- Ruan, Y.H., Wei, W.L., Zhang, H.X., et al. Comparison and analysis of expression of c-myc and pl6 in cervical carcinoma // Ai Zheng. — 2003— Vol.22. — № 6. — P.602−606.
- Saavedra, K., Brebi, P., Roa, J.C. Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix // Clinical Epigenetics. — 2012. — № 4. — P.13.
- Sagawa, Y., Nishi, H., Isaka, K., et al. The correlation of TERT expression with c-myc expression in cervical cancer // Cancer Letters. — 2001. — Vol. 168. — № 1. — P.45−50.
- Scaffidi, C., Fulda, S., Srinivasan, A., et al. Two CD95 (APO-l/Fas) signaling pathways // The EMBO Journal. 1998. — Vol. 17. — № 6. — P. 1675−1687.
- Schmitz, M., Driesch, C., Jansen, L., et al. Non-random integration of the HPV genome in cervical cancer // PLoS One. 2012. — Vol.7. — № 6. — P. e39632.
- Selvaggi, L., Vicino, M., Loverro, G., et al. Lymphocyte subpopulations in patients with cervical cancer // European Journal of Gynaecological Oncology. — 1994. — Vol. 15. — № 1. P.46−49.
- Seresini, S., Origoni, M., Caputo, L., et al. CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix // Immunology. 2010. — Vol. 131. — № 1. — P.89−98.
- Shadeo, A., Chari, R., Vatcher, G., et al. Comprehensive serial analysis of gene expression of the cervical transcriptome // BMC Genomics. — 2007. — № 8. — P. 142.
- Shaulian, E. AP-1 — The Jun proteins: Oncogenes or tumor suppressors in disguise? // Cellular Signalling. 2010. — Vol.22. — P.894−899.
- Shen, Y., Li, Y., Ye, F., et al. Identification of suitable reference genes for measurement of gene expression in human cervical tissues // Analytical Biochemistry. — 2010. — Vol.405. -P.224−229.
- Sheii, B.C., Lin, R.H., Lien, H.C., et al. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer // Journal of Immunology. — 2001. — Vol. 167. № 5. — P.2972−2978.
- Shoji, Y., Saegusa, M., Takano, Y., et al. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma // Journal of Clinical Pathology. 1996. — Vol.49. — № 2. — P. 134−138.
- Sichero, L., Sobrinho, J.S., Villa, L.L. Identification of novel cellular transcription factors that regulate early promoters of human papillomavirus types 18 and 16 // The Journal of Infectious Diseases. 2012. — Vol.206. — № 6. — P.867−874.
- Slagle, B.L., Kaufman, R.H., Reeves, W.C., et al. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia // Cancer. — 1998. — Vol.83. — № 7. — P.1401−1408.
- Sopov, I., Sorensen, T., Magbagbeolu, M., et al. Detection of cancer-related gene expression profiles in severe cervical neoplasia // International Journal of Cancer. — 2004. -Vol.112. — P.33−43.
- Spivak, M.Y., Lakatosh, V.P., Lazarenko, L.M., et al. Interrelation of lymphocyte subpopulations in peripheral blood under cervical papillomavirus infection // Folia Microbiologica (Praha). 1999. — Vol.44. — № 6. — P.721−725.
- Stanley, M.A. Immune responses to human papilloma viruses // Indian Journal of Medical Research. 2009. — Vol.130. — P.266−276.
- Steele, J.C., Mann, C.H., Rookes, S., et al. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia // British Journal of Cancer. 2005. -№ 93. -P.248−259.
- Steinau, M., Rajeevan, M.S., Unger, E.R. DNA and RNA references for qRT-PCR assays in exfoliated cervical cells // The Journal of Molecular Diagnostics. — 2006. — Vol.8. -№ 1. P. 113−118.
- Subramanyam, D., Krishna, S. c-Myc substitutes for Notchl-CBFl functions in cooperative transformation with papillomavirus oncogenes // Virology. — 2006. — Vol.347. — № 1. —P.191−198.
- Tanimoto, H., Nagai, N., Fujimoto, H., et al. Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas // Nihon Sanka Fujinka Gakkai Zasshi. 1992. — Vol.44. -№ 5. — P.566−570.
- Thierry, F. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma // Virology. — 2009. — Vol.384. — P. 375 379.
- Trimble, C.L., Peng, S., Thoburn, C., et al. Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3 // Cancer Immunology, Immunotherapy. 2010. — № 59. — P.799−803.
- Ueda, M., Ueki, M., Kitsuki, K., et al. Study on the management of dysplasia of the uterine cervix // Nihon Sanka Fujinka Gakkai Zasshi. —1992. — Vol.44. — № 9. — P. 1165−1172.
- Velazquez, T.A., Gariglio, V.P. Possible role of transcription factor API in the tissue-specific regulation of human papillomavirus // Revista de Investigacion Clinica. — 2002. — Vol.54. -№ 3. -P.23−42.
- Vervoorts, J., Luscher-Firzlaff, J., Luscher, B. The Ins and Outs of MYC regulation by posttranslational mechanisms // The Journal of Biological Chemistry. — 2006. — Vol.281. -№ 46. -P.34 725−34 729.
- Visser, J., Nijman, H.W., Hoogenboom, B.N., et al. Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia // Clinical and Experimental Immunology. 2007. — Vol.150. — № 2. — P. 199−209.
- Wang, C., Tai, Y., Lisanti, M.P., et al. c-Myc induction of programmed cell death may contribute to carcinogenesis: A perspective inspired by several concepts of chemical carcinogenesis// Cancer Biology and Therapy. —2011. — Vol.11. —№ 7. —P.615−626.
- Wang, W., Fang, Y., Sima, N., et al. Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP // Apoptosis. 2011. — Vol. 16. — № 1. — P.55−66.
- Wang, X., Meyers, C., Wang, H.K., et al. Construction of a full transcription map of human papillomavirus type 18 during productive viral infection // Journal of Virology. — 2011. Vol.85. — №?16. — P.8080−8092.
- Winter, R.N., Kramer, A., Borkowski, A., et al. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer // Cancer Research. — 2001. — Vol.61. — № 3. — P. 1227−1232.
- Wong, Y.F., Rogers, M.S., Cheung, T.H., et al. C-myc mutation detected by polymerase chain reaction-heteroduplex in cervical cancer // Gynecologic and Obstetric Investigation.- 1997. Vol.44. — № 2. — P. 136−140.
- Wu, H.J. The expression of c-myc protein in uterine cervical cancer: a possible prognostic indicator // Nihon Sanka Fujinka Gakkai Zasshi. — 1996. — Vol.48. — № 7. — P.515−521.
- Yang, H.P., Zuna, R.E., Schiffman, M., et al. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3 // PLoS One. — 2012. — Vol.7. — № 1. — P. e2905I.
- Yoshikawa, T., Saito, H., Osaki, T., et al. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer // The Journal of Surgical Research. 2008. — Vol. 148. — № 2. — P. 143−151.
- Young, M.R., Farrell, L., Lambert, P., et al. Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun // Molecular Carcinogenesis. — 2002. — Vol.34. — № 2. — V.12−11.
- Zaatar, A.M., Lim, C.R., Bong, C.W., et al. Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma // Journal of Experimental and Clinical Cancer Research. 2012. — Vol.31. — P.76.
- Zheng, Z.-M., Wang, X. Regulation of cellular miRNA expression by human papillomaviruses // Biochimica et Biophysica Acta. — 2011. — Vol.1809. — № 11−12. — P.668−677.